Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year collaboration. The investment grants GSK a year’s access to 23andMe’s comprehensive consumer DNA data, which includes anonymized genetic information from roughly 80% of customers who have consented to share their data for research purposes. …
Category: Uncategorized
GSK Invests $20 Million in 23andMe for DNA Data Access and Analysis
Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year collaboration. The investment grants GSK a year’s access to 23andMe’s comprehensive consumer DNA data, which includes anonymized genetic information from roughly 80% of customers who have consented to share their data for research purposes. …
GSK Invests $20 Million in 23andMe for DNA Data Access and Analysis
Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year collaboration. The investment grants GSK a year’s access to 23andMe’s comprehensive consumer DNA data, which includes anonymized genetic information from roughly 80% of customers who have consented to share their data for research purposes. …